Article
A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease
6 Jul 2021
Abstract excerpt
The COVID-19 outbreak has caused a health crisis and economic hardship across the world, and the sudden deterioration of COVID-19 patients into a severe type of illness is a major cause of the high mortality in current pandemic. Since medical facilities do not have reliable biomarkers to predict likelihood of disease progression and identify high-risk patients that require immediate medical attention, patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.